BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18853582)

  • 1. How well do serum sTREM-1 measurements prognosticate in septic shock?
    Phua J; Koay ES; Zhang D; Lee KH
    Anaesth Intensive Care; 2008 Sep; 36(5):654-8. PubMed ID: 18853582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock.
    Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA
    PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of soluble triggering receptor expressed on myeloid cells-1 in critically-ill, postoperative patients with suspected sepsis.
    Li L; Zhu Z; Chen J; Ouyang B; Chen M; Guan X
    Am J Med Sci; 2013 Mar; 345(3):178-84. PubMed ID: 22739556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study.
    Li Z; Wang H; Liu J; Chen B; Li G
    Mediators Inflamm; 2014; 2014():641039. PubMed ID: 24672147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
    Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
    Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study.
    Su L; Han B; Liu C; Liang L; Jiang Z; Deng J; Yan P; Jia Y; Feng D; Xie L
    BMC Infect Dis; 2012 Jul; 12():157. PubMed ID: 22809118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study.
    Zhang J; She D; Feng D; Jia Y; Xie L
    BMC Infect Dis; 2011 Mar; 11():53. PubMed ID: 21356122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Serum sTREM-1 Correlates With Myocardial Dysfunction and Predicts Prognosis in Septic Patients.
    Li Z; Zhang E; Hu Y; Liu Y; Chen B
    Am J Med Sci; 2016 Jun; 351(6):555-62. PubMed ID: 27238916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock.
    Phua J; Koay ES; Lee KH
    Shock; 2008 Mar; 29(3):328-33. PubMed ID: 18277855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.
    Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S
    BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction.
    Su L; Feng L; Song Q; Kang H; Zhang X; Liang Z; Jia Y; Feng D; Liu C; Xie L
    Mediators Inflamm; 2013; 2013():969875. PubMed ID: 23935252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
    Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
    J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble TREM-1 as a diagnostic and prognostic biomarker in patients with septic shock: an observational clinical study.
    Brenner T; Uhle F; Fleming T; Wieland M; Schmoch T; Schmitt F; Schmidt K; Zivkovic AR; Bruckner T; Weigand MA; Hofer S
    Biomarkers; 2017 Feb; 22(1):63-69. PubMed ID: 27319606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis.
    Halim B; Özlem T; Melek Ç; Münip Hakan Y; Cevval U; Gönül DH; Çiğdem Banu Ç
    Turk J Med Sci; 2015; 45(3):578-86. PubMed ID: 26281323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of sTREM-1, procalcitonin and CRP as laboratory parameters for postmortem diagnosis of sepsis.
    Palmiere C; Bardy D; Mangin P; Augsburger M
    J Infect; 2013 Dec; 67(6):545-55. PubMed ID: 24012914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness.
    Jeong SJ; Song YG; Kim CO; Kim HW; Ku NS; Han SH; Choi JY; Kim JM
    Shock; 2012 Jun; 37(6):574-8. PubMed ID: 22395243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis.
    Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M
    Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin as a marker of severity in septic shock.
    Schröder J; Staubach KH; Zabel P; Stüber F; Kremer B
    Langenbecks Arch Surg; 1999 Feb; 384(1):33-8. PubMed ID: 10367627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock.
    Jedynak M; Siemiatkowski A; Mroczko B; Groblewska M; Milewski R; Szmitkowski M
    Arch Immunol Ther Exp (Warsz); 2018 Aug; 66(4):299-306. PubMed ID: 29282483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.